Mark James Docherty
Algemeen Directeur bij DHP Private Equity GmbH
Oorsprong van het eerstegraads netwerk van Mark James Docherty
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 15 | |
Excalibur Fund Managers Ltd.
 Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom.
11
| Subsidiary | Investment Managers | 11 |
| Subsidiary | Pharmaceuticals: Major | 6 | |
Trizell Ltd.
 Trizell Ltd. BiotechnologyHealth Technology Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom.
4
| Private Company | Biotechnology | 4 |
DHP Private Equity GmbH
1
| Private Company | Investment Managers | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mark James Docherty via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
| VECTURA GROUP | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
Zeneus Pharma Ltd.
 Zeneus Pharma Ltd. Medical DistributorsDistribution Services Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK. | Medical Distributors | Founder Chief Tech/Sci/R&D Officer | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
Trigemina, Inc.
 Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Pharmaceuticals: Major | Director/Board Member | |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
| E-THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| ANGELFISH INVESTMENTS PLC | Investment Managers | Director/Board Member Chairman | |
The Institute of Cancer Research: Royal Cancer Hospital
 The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services The Institute of Cancer Research: Royal Cancer Hospital operates as a cancer research institution. The company was founded in 1909 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member | |
| STADA ARZNEIMITTEL | Pharmaceuticals: Major | Director/Board Member | |
| GENMAB A/S | Pharmaceuticals: Major | Director/Board Member | |
| BIOTEST AG | Pharmaceuticals: Other | Chairman | |
Celsis International Ltd.
 Celsis International Ltd. Medical SpecialtiesHealth Technology Celsis International Ltd. develops and supplies medical diagnostic products and laboratory services. The company was founded by Sir Christopher Evans in 1992 and is headquartered in Westminster, the United Kingdom. | Medical Specialties | Founder Founder | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
| THE BIOTECH GROWTH TRUST PLC | Investment Trusts/Mutual Funds | Founder Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree | |
| Imperial College London | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| PHYSIOMICS PLC | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Simbec Research Ltd.
 Simbec Research Ltd. Miscellaneous Commercial ServicesCommercial Services Simbec Research Ltd. provides clinical research service to pharmaceutical and biotechnology industries. It conducts drug trails for allergy, anti-infectives, cardiovascular, gastrointestinal, anti-inflammatory, oncology and respiratory. The firm also offers consultancy services, preparation of marketing authorization applications, and clinical trial applications. The company was founded in 1976 and is headquartered in Merthyr Tydfil, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
| University of London | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of Birmingham | College/University | Undergraduate Degree Undergraduate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
ReNeuron Ltd.
 ReNeuron Ltd. BiotechnologyHealth Technology ReNeuron Ltd. researches and develops drugs, diagnostics, and other therapeutic products. The company was founded on May 23, 1997 and is headquartered in Bridgend, the United Kingdom. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| The University of Hull | College/University | Doctorate Degree Undergraduate Degree | |
| London Business School | College/University | Masters Business Admin Corporate Officer/Principal | |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| King's College London | College/University | Corporate Officer/Principal Doctorate Degree | |
Excalibur Group Holdings Ltd.
 Excalibur Group Holdings Ltd. Financial ConglomeratesFinance Excalibur Group Holdings Ltd. is a private company based in London, UK. and has subsidiaries in the United Kingdom, the British Virgin Islands, Germany and Sweden. The British company was founded by Christopher Thomas Evans. | Financial Conglomerates | Director/Board Member Founder | |
| Cyclacel Ltd. | Director/Board Member Director of Finance/CFO | ||
GlaxoSmithKline Services Unlimited
 GlaxoSmithKline Services Unlimited Pharmaceuticals: MajorHealth Technology Glaxosmithkline Services Unlimited Ltd. develops, manufactures and markets pharmaceutical products. The company was incorporated on March 23, 1972 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Oval Medical Technologies Ltd.
 Oval Medical Technologies Ltd. Medical SpecialtiesHealth Technology Oval Medical Technologies Ltd. manufactures drug delivery devices focusing on vials, prefilled syringes, and autoinjectors. It provides an environment for the storage of all drugs including fragile biologics. The company was founded by Matthew Young in 2009 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Chairman Chairman | |
Neurocentrx Pharma Ltd.
 Neurocentrx Pharma Ltd. Pharmaceuticals: MajorHealth Technology Neurocentrx Pharma Ltd. is a British pharmaceutical company that manufactures and distributes medicines. The company is based in Edinburgh, UK. Neurocentrx Pharma was founded by Howard Marriage, Ronald M. Lindsay, and Carmel Reilly. Carmel Reilly has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Ieso Digital Health Ltd.
 Ieso Digital Health Ltd. Commercial Printing/FormsCommercial Services Ieso Digital Health Ltd. provides Internet enabled mental health services to health providers, private individuals and businesses. The firm engages in delivering cognitive behavioral therapy. It offers anxiety, bereavement, child and family, depression, drug and alcohol misuse, eating disorder, managing anger, managing pain, obsessive compulsive disorder, panic, phobia, post traumatic stress, relationship, sexual difficulty, sports psychology, stress management, and terminal illness therapy services. The company was founded by Barnaby Perks, Sue Wright and Nadine Field in 2000 and is headquartered in Cambridge, the United Kingdom. | Commercial Printing/Forms | Chairman Chairman | |
Arix Capital Management Ltd.
 Arix Capital Management Ltd. Investment ManagersFinance Arix Capital Management Ltd (Arix Capital Management) is a venture capital subsidiary of Arix Bioscience Plc founded in 2012 by Christopher Thomas Evans. The firm is headquartered in Cardiff, United Kingdom. | Investment Managers | Chief Executive Officer Director/Board Member Founder Director of Investments | |
Simbec-Orion Group Ltd.
 Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | Pharmaceuticals: Major | Private Equity Investor Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Chairman Director/Board Member | |
| SHIELD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ARIX BIOSCIENCE PLC | Investment Managers | Founder Director/Board Member | |
NavBio AG
 NavBio AG Miscellaneous Commercial ServicesCommercial Services NavBio AG provides business and management consulting services. | Miscellaneous Commercial Services | Director/Board Member | |
| Trizell Holding SA | Director/Board Member Founder | ||
EDX Medical Ltd.
 EDX Medical Ltd. Medical/Nursing ServicesHealth Services Part of EDX Medical Group Plc, EDX Medical Ltd. is a British company that operates as a digital diagnostics. The company is based in Cambridge, UK. The company was founded by Christopher Thomas Evans. The CEO is Michael John Hudson. EDX Medical was acquired by TECC Capital Plc on November 14, 2022 for $6.88 million. | Medical/Nursing Services | Director/Board Member Founder | |
EDX Medical Group Plc
 EDX Medical Group Plc Medical/Nursing ServicesHealth Services EDX Medical Group Plc engages in the provision of medical goods in the United Kingdom. It distributes Guardant Health’s cancer genomic tests for healthcare providers in Sweden, Denmark, Norway, Finland and Iceland (Nordics), also serving the private healthcare sector in the United Kingdom. The company was founded by Christopher Thomas Evans and Michael Hudson John on March 19, 2021 and is headquartered in Cambridge, the United Kingdom. | Medical/Nursing Services | Director/Board Member Founder | |
| World Anti-Doping Agency | Director/Board Member |
Statistieken
Internationaal
| Verenigd Koninkrijk | 40 |
| Verenigde Staten | 4 |
| Duitsland | 3 |
| Zwitserland | 3 |
| Ierland | 2 |
Sectoraal
| Health Technology | 22 |
| Commercial Services | 10 |
| Consumer Services | 8 |
| Finance | 5 |
| Distribution Services | 3 |
Operationeel
| Director/Board Member | 287 |
| Chairman | 82 |
| Corporate Officer/Principal | 58 |
| Independent Dir/Board Member | 49 |
| Founder | 42 |
Sterkste connecties
| Insiders | |
|---|---|
| Christopher Evans | 62 |
| Jeremy Curnock-Cook | 60 |
| Simon Cartmell | 39 |
| Trevor Jones | 36 |
| Susan Foden | 32 |
| Rolf K. Hoffmann | 27 |
| Peter Stephen Keen | 25 |
| John Berriman | 24 |
| Jean Duvall | 22 |
| Bryan Geoffrey Morton | 22 |
| Paul Harper | 20 |
| Timothy Corn | 20 |
| Martin Walton | 16 |
| Olav Hellebø | 13 |
| Brenig Preest | 11 |
- Beurs
- Insiders
- Mark James Docherty
- Bedrijfsconnecties
